Form 4 for PLRX PLIANT THERAPEUTICS, INC.
Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-11 · accession 0001567619-22-013993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-13 | 2022-07-11+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $22.50 | -27.5K | 59.3K | -32% | -$618.7K |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +27.5K | 74.3K | +59% | +$57.2K |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $0.00 | -27.5K | 309.9K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-12 | S | D | 12,498 | $22.50 | 59,273 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-12 | M | A | 12,498 | $2.08 | 71,771 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-11 | M | A | 15,000 | $2.08 | 74,273 | D | — | — | (F2) Includes 4,433 shares of Common Stock acquired by the reporting person pursuant to an employee stock purchase program. |
| 4 | Common | Common Stock | 2022-07-11 | S | D | 15,000 | $22.50 | 59,273 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2022-07-11 | M | D | 15,000 | $0.00 | 322,380 | D | $2.08 · — to 2029-01-23 | 15,000 Common Stock | (F4) 1/48th of the shares subject to the original option grant vest and become exercisable in substantially equal installments on each monthly anniversary of January 24, 2019, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 6 | Derivative | Stock Option (right to buy) | 2022-07-12 | M | D | 12,498 | $0.00 | 309,882 | D | $2.08 · — to 2029-01-23 | 12,498 Common Stock | (F4) 1/48th of the shares subject to the original option grant vest and become exercisable in substantially equal installments on each monthly anniversary of January 24, 2019, subject to the Reporting Person's continuous service to the Issuer on each such date. |